Skip to main content

Drug Interactions between Moderna COVID-19 Bivalent Vaccine PF and Shingrix

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs


zoster vaccine, recombinant SARS-CoV-2 (COVID-19) mRNA-1273 bivalent vaccine

Applies to: Shingrix (zoster vaccine, recombinant) and Moderna COVID-19 Bivalent Vaccine PF (sars-cov-2 (covid-19) mrna-1273 (bivalent booster) vaccine)

The safety and effectiveness of SARS-CoV-2 (COVID-19) mRNA-1273 bivalent vaccine given at the same time with another vaccine or within a short period of each other have not been studied. Whether it is preferable to administer the vaccines together during the same visit (or shortly after one another) or wait at least 14 days in between each vaccine may be dependent on a number of factors including if the patient is behind or at risk of becoming behind on recommended vaccines, their risk of vaccine-preventable disease (e.G., during an outbreak or occupational exposures), and the side effects of the vaccines. Talk to your doctor or other healthcare providers if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Report options

QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.